1. Home
  2. ABTS vs CHRO Comparison

ABTS vs CHRO Comparison

Compare ABTS & CHRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABTS
  • CHRO
  • Stock Information
  • Founded
  • ABTS 2010
  • CHRO 2002
  • Country
  • ABTS Hong Kong
  • CHRO United States
  • Employees
  • ABTS N/A
  • CHRO N/A
  • Industry
  • ABTS Computer Software: Programming Data Processing
  • CHRO
  • Sector
  • ABTS Technology
  • CHRO
  • Exchange
  • ABTS Nasdaq
  • CHRO Nasdaq
  • Market Cap
  • ABTS 15.9M
  • CHRO 16.8M
  • IPO Year
  • ABTS N/A
  • CHRO 2024
  • Fundamental
  • Price
  • ABTS $0.47
  • CHRO $1.66
  • Analyst Decision
  • ABTS
  • CHRO Strong Buy
  • Analyst Count
  • ABTS 0
  • CHRO 1
  • Target Price
  • ABTS N/A
  • CHRO N/A
  • AVG Volume (30 Days)
  • ABTS 76.0K
  • CHRO 2.5M
  • Earning Date
  • ABTS 12-31-2024
  • CHRO 02-20-2025
  • Dividend Yield
  • ABTS N/A
  • CHRO N/A
  • EPS Growth
  • ABTS N/A
  • CHRO N/A
  • EPS
  • ABTS N/A
  • CHRO N/A
  • Revenue
  • ABTS $5,343,888.00
  • CHRO N/A
  • Revenue This Year
  • ABTS N/A
  • CHRO N/A
  • Revenue Next Year
  • ABTS N/A
  • CHRO N/A
  • P/E Ratio
  • ABTS N/A
  • CHRO N/A
  • Revenue Growth
  • ABTS 3970.67
  • CHRO N/A
  • 52 Week Low
  • ABTS $0.38
  • CHRO $0.45
  • 52 Week High
  • ABTS $1.07
  • CHRO $6.00
  • Technical
  • Relative Strength Index (RSI)
  • ABTS 46.52
  • CHRO 49.86
  • Support Level
  • ABTS $0.44
  • CHRO $1.96
  • Resistance Level
  • ABTS $0.59
  • CHRO $2.65
  • Average True Range (ATR)
  • ABTS 0.04
  • CHRO 0.66
  • MACD
  • ABTS -0.00
  • CHRO -0.04
  • Stochastic Oscillator
  • ABTS 21.85
  • CHRO 28.43

About ABTS Abits Group Inc

Abits Group Inc is a digital data center operator with bitcoin self-mining operations.

About CHRO Chromocell Therapeutics Corporation

Channel Therapeutics Corp is a clinical-stage biotechnology company developing and commercializing novel, non-opioid, non-addictive therapeutics to alleviate pain. The initial clinical focus is to selectively target the sodium ion channel known as NaV1.7 for the treatment of various types of chronic pain, acute and chronic eye pain, and post-surgical nerve blocks. Its pipeline includes CC8464 for ISFN and EM and CT2000 for Acute and CHronic Eye Pain-Dry Eye Disease.

Share on Social Networks: